iOS app Android app

Fda Biosimilars

U.S. Pharma Industry Getting Ready for a Shake Up

Jessica Stone | Posted 04.30.2015 | Business
Jessica Stone

In the coming weeks, a single drug will revolutionize the U.S. pharmaceutical industry. Zarxio, a drug that reduces infections caused by chemotherapy, is about to become the very first biosimilar drug sold in the United States.

Approved Pathway for Biosimilars Must Be Patient-Focused

Eva M. Clayton | Posted 08.25.2012 | Healthy Living
Eva M. Clayton

The U.S. pharmaceutical industry has worked hard to become an international leader in the production of biotech drugs. But as the nation introduces these medicines, we need to ensure that safety protocols are in place -- so that every patient has the opportunity to get healthy.

Are Unsafes Drugs An 'Acceptable Risk?' FDA Should Say 'No!'

John Horton | Posted 05.25.2011 | Home
John Horton

As a matter of common sense, the FDA's process for biosimilars shouldn't sacrifice patient safety.